S
Soona Shin
Researcher at University of Pennsylvania
Publications - 29
Citations - 2545
Soona Shin is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Liver cancer & Progenitor cell. The author has an hindex of 18, co-authored 26 publications receiving 2206 citations. Previous affiliations of Soona Shin include Johns Hopkins University & Seoul National University.
Papers
More filters
Journal ArticleDOI
When NRF2 Talks, Who's Listening?
TL;DR: This review highlights recent observations on the molecular interactions and their functional consequences between NRF2 and the arylhydrocarbon receptor (AhR), NF-κB, p53, and Notch1 signaling pathways, which provide a multi-tiered, integrated response to chemical stresses.
Journal ArticleDOI
NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis.
Soona Shin,Nobunao Wakabayashi,Vikas Misra,Shyam Biswal,Gum Hwa Lee,Elin S. Agoston,Masayuki Yamamoto,Thomas W. Kensler +7 more
TL;DR: NRF2 regulates expression of Ahr and subsequently modulates several downstream events of the AHR signaling cascade, including inhibition of adipogenesis in mouse embryonic fibroblasts (MEFs) and bidirectional interactions of these pathways.
Journal ArticleDOI
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
Soona Shin,Junko Wakabayashi,Melinda S. Yates,Nobunao Wakabayashi,Patrick M. Dolan,Susan Aja,Karen T. Liby,Michael B. Sporn,Masayuki Yamamoto,Thomas W. Kensler +9 more
TL;DR: It is indicated that CDDO-Im is an exceedingly potent agent for preventing obesity, and the Nrf2 pathway is identified as a novel target for management of obesogenesis.
Journal ArticleDOI
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice
Melinda S. Yates,Quynh T. Tran,Patrick M. Dolan,William O. Osburn,Soona Shin,Colin Craig McCulloch,Jay B. Silkworth,Keiko Taguchi,Masayuki Yamamoto,Charlotte R. Williams,Karen T. Liby,Michael B. Sporn,Thomas R. Sutter,Thomas W. Kensler +13 more
TL;DR: Analysis of pharmacologic activation suggests that Nrf2 is the primary mediator of CDDO-Im activity, though other cell-signaling targets are also modulated following an oral dose of 30 micromol/kg.
Journal ArticleDOI
Foxl1-Expressing Mesenchymal Cells Constitute the Intestinal Stem Cell Niche
Reina Aoki,Michal Shoshkes-Carmel,Nan Gao,Soona Shin,Catherine Lee May,Maria L. Golson,Adam M. Zahm,Michael Ray,Caroline L. Wiser,Christopher V.E. Wright,Klaus H. Kaestner +10 more
TL;DR: Killing Foxl1+ cells by diphtheria toxin administration led to an abrupt cessation of proliferation of both epithelial stem- and transit-amplifying progenitor cell populations that was associated with a loss of active Wnt signaling to the intestinal epithelium, therefore, Foxl 1-expressing mesenchymal cells constitute the fundamental niche for intestinal stem cells.